Annual SG&A
$1.83 M
+$1.80 M+5071.47%
31 December 2023
Summary:
Bellevue Life Sciences Acquisit annual selling, general & administrative expenses is currently $1.83 million, with the most recent change of +$1.80 million (+5071.47%) on 31 December 2023. During the last 3 years, it has risen by +$1.83 million (+55375.76%). BLACU annual SG&A is now -99.26% below its all-time high of $246.19 million, reached on 01 December 2020.BLACU Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$454.10 K
-$21.40 K-4.50%
30 September 2024
Summary:
Bellevue Life Sciences Acquisit quarterly selling, general & administrative expenses is currently $454.10 thousand, with the most recent change of -$21.40 thousand (-4.50%) on 30 September 2024. Over the past year, it has increased by +$43.70 thousand (+10.65%). BLACU quarterly SG&A is now -47.31% below its all-time high of $861.90 thousand, reached on 31 December 2023.BLACU Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
-$18.87 M
-$3.30 M-21.18%
30 September 2024
Summary:
Bellevue Life Sciences Acquisit TTM selling, general & administrative expenses is currently -$18.87 million, with the most recent change of -$3.30 million (-21.18%) on 30 September 2024. Over the past year, it has dropped by -$19.86 million (-2019.72%). BLACU TTM SG&A is now -69541.33% below its all-time high of $2.24 million, reached on 30 September 2024.BLACU TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BLACU Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +5071.5% | +10.7% | -2019.7% |
| 3 y3 years | +10000.0% | +10000.0% | -10000.0% |
| 5 y5 years | -99.2% | - | - |
BLACU Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | >+9999.0% | -47.3% | >+9999.0% | <-9999.0% | at low |
| 5 y | 5 years | -99.3% | >+9999.0% | -47.3% | >+9999.0% | <-9999.0% | at low |
| alltime | all time | -99.3% | >+9999.0% | -47.3% | >+9999.0% | <-9999.0% | at low |
Bellevue Life Sciences Acquisit Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $454.10 K(-4.5%) | $2.24 M(+2.0%) |
| June 2024 | - | $475.50 K(+5.5%) | $2.20 M(+9.7%) |
| Mar 2024 | - | $450.80 K(-47.7%) | $2.00 M(+9.4%) |
| Dec 2023 | $1.83 M(+5071.5%) | $861.90 K(+110.0%) | $1.83 M(+86.2%) |
| Sept 2023 | - | $410.40 K(+46.4%) | $983.10 K(+65.9%) |
| June 2023 | - | $280.30 K(+0.8%) | $592.70 K(+89.1%) |
| Mar 2023 | - | $278.10 K(+1844.8%) | $313.40 K(+785.3%) |
| Dec 2022 | $35.40 K | - | - |
| Dec 2022 | - | $14.30 K(-28.5%) | $35.40 K(+65.4%) |
| Sept 2022 | - | $20.00 K(+1900.0%) | $21.40 K(+1326.7%) |
| June 2022 | - | $1000.00(+900.0%) | $1500.00(-53.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $100.00(-66.7%) | $3200.00(+3.2%) |
| Dec 2021 | $3300.00(-100.0%) | $300.00(+200.0%) | $3100.00(+10.7%) |
| Sept 2021 | - | $100.00(-96.3%) | $2800.00(+3.7%) |
| June 2021 | - | $2700.00 | $2700.00 |
| Dec 2020 | $246.19 M(+14.6%) | - | - |
| Dec 2019 | $214.89 M(+22.1%) | - | - |
| Dec 2018 | $176.00 M(+19.9%) | - | - |
| Dec 2017 | $146.73 M(+38.8%) | - | - |
| Dec 2016 | $105.72 M(+36.5%) | - | - |
| Dec 2015 | $77.47 M(+77.9%) | - | - |
| Dec 2014 | $43.55 M | - | - |
FAQ
- What is Bellevue Life Sciences Acquisit annual selling, general & administrative expenses?
- What is the all time high annual SG&A for Bellevue Life Sciences Acquisit?
- What is Bellevue Life Sciences Acquisit annual SG&A year-on-year change?
- What is Bellevue Life Sciences Acquisit quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for Bellevue Life Sciences Acquisit?
- What is Bellevue Life Sciences Acquisit quarterly SG&A year-on-year change?
- What is Bellevue Life Sciences Acquisit TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for Bellevue Life Sciences Acquisit?
- What is Bellevue Life Sciences Acquisit TTM SG&A year-on-year change?
What is Bellevue Life Sciences Acquisit annual selling, general & administrative expenses?
The current annual SG&A of BLACU is $1.83 M
What is the all time high annual SG&A for Bellevue Life Sciences Acquisit?
Bellevue Life Sciences Acquisit all-time high annual selling, general & administrative expenses is $246.19 M
What is Bellevue Life Sciences Acquisit annual SG&A year-on-year change?
Over the past year, BLACU annual selling, general & administrative expenses has changed by +$1.80 M (+5071.47%)
What is Bellevue Life Sciences Acquisit quarterly selling, general & administrative expenses?
The current quarterly SG&A of BLACU is $454.10 K
What is the all time high quarterly SG&A for Bellevue Life Sciences Acquisit?
Bellevue Life Sciences Acquisit all-time high quarterly selling, general & administrative expenses is $861.90 K
What is Bellevue Life Sciences Acquisit quarterly SG&A year-on-year change?
Over the past year, BLACU quarterly selling, general & administrative expenses has changed by +$43.70 K (+10.65%)
What is Bellevue Life Sciences Acquisit TTM selling, general & administrative expenses?
The current TTM SG&A of BLACU is -$18.87 M
What is the all time high TTM SG&A for Bellevue Life Sciences Acquisit?
Bellevue Life Sciences Acquisit all-time high TTM selling, general & administrative expenses is $2.24 M
What is Bellevue Life Sciences Acquisit TTM SG&A year-on-year change?
Over the past year, BLACU TTM selling, general & administrative expenses has changed by -$19.86 M (-2019.72%)